98%
921
2 minutes
20
Background: Experiencing a patient's death after a resuscitation effort can be emotionally traumatizing to health care professionals. In a large community teaching hospital, the code blue team implemented "The Pause" as a coping strategy to support the well-being of the interprofessional health care team.
Objectives: To assess the impact of the Pause on compassion fatigue, distress, and mindfulness and to explore clinicians' experiences with patients' death after a code blue event and use of the Pause.
Methods: This multimethod study included preimplementation and postimplementation surveys and interviews of clinical and nonclinical health care staff who respond to house-wide code blue events.
Results: The Pause intervention was implemented in fall 2021; 64 preimplementation surveys were collected in May 2021, and 74 postimplementation surveys were collected in August 2022. Compassion fatigue scores decreased after implementation, and mindfulness scores increased; however, neither change was statistically significant. During the COVID-19 pandemic, participants reported more distress from patient deaths after a code blue event. Qualitative interviews yielded themes such as the impact of the COVID-19 pandemic on death, emotionally coping with death, and the Pause as humanizing.
Conclusions: The Pause was perceived as a helpful coping strategy for code blue-related patient death; however, the COVID-19 pandemic made it difficult to measure intervention effects. The Pause may also offer an opportunity to support and empower health care professionals during an impactful moment, such as witnessing death.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4037/ajcc2025556 | DOI Listing |
Resusc Plus
November 2025
Department of Emergency Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan city, Taiwan.
Resusc Plus
November 2025
Helicopter Emergency Medical Service Lifeliner 3, Nijmegen, the Netherlands.
Background: Out-of-hospital cardiac arrest management prioritises effective treatment, with high-quality chest compressions and timely defibrillation being essential. While current European Resuscitation Council guidelines recommend sternal-apical defibrillator pad placement, alternative positions such as anterior-posterior (AP) are gaining interest. The integration of secondary AP pad placement with mechanical cardiopulmonary resuscitation devices (mCPR) remains underexplored.
View Article and Find Full Text PDFResusc Plus
November 2025
Prehospital, Resuscitation and Emergency Care Research Unit (PRECRU), Curtin School of Nursing, Curtin University, Bentley, Western Australia, Australia.
Purpose: To measure the quality of cardiopulmonary resuscitation (CPR) provided by Emergency Medical Services (EMS) personnel wearing 'enhanced' personal protective equipment (PPE) during the COVID-19 pandemic in Perth, Australia.
Methods: We undertook a retrospective cohort study of adult, non-traumatic, non-EMS-witnessed out-of-hospital cardiac arrests (OHCA) with resuscitation attempted by St John (Ambulance) Western Australia (SJWA) between 16/03/2020-16/05/2021; corresponding to the first 14 months of the COVID-19 pandemic. We reported the median (interquartile range [IQR]) compression depth, rate and fraction across the cohort, along with the proportion of cases compliant with resuscitation guidelines issued by the Australian and New Zealand Committee on Resuscitation (ANZCOR).
Cureus
August 2025
Emergency and Critical Care Center, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Haebaru, JPN.
The indications for extracorporeal membrane oxygenation (ECMO) have broadened in clinical practice, and its use in circulatory failure caused by acute drug intoxication has become more frequent. We reviewed three cases of venoarterial (VA) ECMO use for intoxication at our hospital. Three cases (aged 60-69 years) developed refractory shock following intentional overdose, including calcium channel blockers.
View Article and Find Full Text PDFFront Pharmacol
August 2025
Department of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou, China.
Loperamide is a medication commonly used to treat acute and chronic diarrhea and is generally considered safe because it poorly crosses the blood-brain barrier at therapeutic doses. However, in recent years, with the abuse and overdose of loperamide, its potential cardiotoxicity and central nervous system depression have increasingly raised concerns. This article reports a case of a 15-year-old male patient who died from poisoning after a single ingestion of 60 mg of loperamide.
View Article and Find Full Text PDF